Abstract：
Treatment of ischemic cardiomyopathy has been the focus of increased attention by cardiologists due to recent evidence of an important outcome study comparing percutaneous coronary intervention (PCI) plus optimal medical treatment vs optimal medical treatment alone, concluding for the futility of myocardial revascularization by PCI. A relatively older trial of coronary artery bypass grafting (CABG) in the same condition, on the other hand, had concluded for some prognostic improvement at a long-term follow-up. This short manuscript addresses how to triage such patients, frequently encountered in medical practice and considering clinical presentation, imaging results, and surgical risk, to provide practical guidance to treatment.
摘要：
缺血性心肌病的治疗已成为心脏病学家日益关注的焦点，因为最近有证据表明，一项重要的结果研究将经皮冠状动脉介入治疗（PCI）加最佳药物治疗与单独的最佳药物治疗进行了比较。结论PCI心肌血运重建无效。在相同条件下进行的冠状动脉旁路移植术（CABG）的相对较早的试验，另一方面,在长期随访中得出了一些预后改善的结论。这篇简短的手稿讲述了如何对这些患者进行分类，在医疗实践中经常遇到，并考虑临床表现，成像结果,和手术风险，为治疗提供实际指导。
